Annexon, Inc. (NASDAQ:ANNX) was able to achieve positive results from its phase 3 study for the treatment of patients with Guillain-Barré syndrome [GBS]. Matter...
Investment Summary Since my last report on Integer Holdings Corporation (NYSE:ITGR), the stock has experienced a substantial re-rating, surging nearly 60% from my previous...